FRONT NUTR 润色咨询

Frontiers in Nutrition

出版年份:暂无数据 年文章数:2780 投稿命中率: 开通期刊会员,数据随心看

出版周期:C 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2122929, encodeId=175121229295a, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:营养<br>经验分享:常规实验文章,投稿到接收4个月左右,交了版面费很快就出刊了。 2个审稿人都是美国的。1是个大佬,问了很多细致的问题,也给了一些值得思考的建议,一一对应改好了,就给过了。2是个博后,问了几个常规的问题,也是回答就给过了。 总的来说,这两个审稿人挺友善的,杂志也很负责,要了伦理审核的东西,wb的原图,Qpcr 原数据我都附上了,都是比较规范的。 老老实实都附上,应该就会快一些吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a7f5533568, createdName=韦钰, createdTime=Fri Mar 31 10:39:08 CST 2023, time=2023-03-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2097683, encodeId=2542209e68340, content=最近是不是变慢了,10天还没分配AE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=010f8147904, createdName=ms9000000819717463, createdTime=Mon Oct 31 21:13:24 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207713, encodeId=7548120e7138b, content=微博吃瓜,投这个,哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Fri Apr 01 00:42:17 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149116, encodeId=a686214911689, content=一审2个月,不知道多久能完事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=168c2506707, createdName=发发发biu, createdTime=Fri Jul 21 09:52:15 CST 2023, time=2023-07-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2091816, encodeId=38662091816cf, content=偏重的研究方向:营养<br>经验分享:这个杂志到底按一区还是二区啊?看到中科院升级版是二区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqFQ0gs98ltXQ4kLkU7MnunH93d2ribAxPw8ImaU4UYv9NbJibibu7uPBpkESFCaibVGYQwXhxyW43icag/132, createdBy=b7021639769, createdName=babytree, createdTime=Tue Oct 04 23:29:57 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227696, encodeId=a7e0122e696f4, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:两个审稿人的审稿意见已经通过邮件的形式单独发过来了,不知道是不是还有其他审稿人。请问在哪回复审稿意见啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e196164717, createdName=ms8000001967238880, createdTime=Tue Jun 21 10:19:53 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113782, encodeId=8f091113e8206, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113781, encodeId=4ca11113e81fd, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188521, encodeId=6f7d2188521d0, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:营养流行病学<br>经验分享:23年10月投稿,一直待分配编辑,1个月后找到编辑,紧接着送审,审稿周期2个月,大修接收,2月19日接收,整个周期耗时4个月,好在结果不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10768099093, createdName=ms8000000199900887, createdTime=Wed Feb 21 15:42:18 CST 2024, time=2024-02-21, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2147131, encodeId=4dbd214e1314e, content=偏重的研究方向:流行病学<br>经验分享:5月份团队一篇文章被fin接收,2天后我们缴纳apc,之后突然审稿系统退到第6步,状态显示编辑要进行技术审查之类的。我们一直以为是新影响因子出来前控制稿件数量的策略,也就没在意,期间给中国编辑部发了邮件,编辑部说会跟进。新IF出来后,竟然以稿件不符合期刊标准直接拒了,你敢信??????发两封邮件质疑其初衷,直接无视,只提到apc会退回!!!目前apc还没退到账户,至于各位投还是不投,frontiers还能不能水,自己定夺!!!!!!以后应该不会投这个杂志了,出尔反尔,不知其可!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c95495864, createdName=ms8000000158580549, createdTime=Sun Jul 09 15:56:52 CST 2023, time=2023-07-09, status=1, ipAttribution=重庆)]
    2023-03-31 韦钰 来自广东省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:营养
    经验分享:常规实验文章,投稿到接收4个月左右,交了版面费很快就出刊了。 2个审稿人都是美国的。1是个大佬,问了很多细致的问题,也给了一些值得思考的建议,一一对应改好了,就给过了。2是个博后,问了几个常规的问题,也是回答就给过了。 总的来说,这两个审稿人挺友善的,杂志也很负责,要了伦理审核的东西,wb的原图,Qpcr 原数据我都附上了,都是比较规范的。 老老实实都附上,应该就会快一些吧。

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2122929, encodeId=175121229295a, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:营养<br>经验分享:常规实验文章,投稿到接收4个月左右,交了版面费很快就出刊了。 2个审稿人都是美国的。1是个大佬,问了很多细致的问题,也给了一些值得思考的建议,一一对应改好了,就给过了。2是个博后,问了几个常规的问题,也是回答就给过了。 总的来说,这两个审稿人挺友善的,杂志也很负责,要了伦理审核的东西,wb的原图,Qpcr 原数据我都附上了,都是比较规范的。 老老实实都附上,应该就会快一些吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a7f5533568, createdName=韦钰, createdTime=Fri Mar 31 10:39:08 CST 2023, time=2023-03-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2097683, encodeId=2542209e68340, content=最近是不是变慢了,10天还没分配AE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=010f8147904, createdName=ms9000000819717463, createdTime=Mon Oct 31 21:13:24 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207713, encodeId=7548120e7138b, content=微博吃瓜,投这个,哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Fri Apr 01 00:42:17 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149116, encodeId=a686214911689, content=一审2个月,不知道多久能完事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=168c2506707, createdName=发发发biu, createdTime=Fri Jul 21 09:52:15 CST 2023, time=2023-07-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2091816, encodeId=38662091816cf, content=偏重的研究方向:营养<br>经验分享:这个杂志到底按一区还是二区啊?看到中科院升级版是二区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqFQ0gs98ltXQ4kLkU7MnunH93d2ribAxPw8ImaU4UYv9NbJibibu7uPBpkESFCaibVGYQwXhxyW43icag/132, createdBy=b7021639769, createdName=babytree, createdTime=Tue Oct 04 23:29:57 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227696, encodeId=a7e0122e696f4, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:两个审稿人的审稿意见已经通过邮件的形式单独发过来了,不知道是不是还有其他审稿人。请问在哪回复审稿意见啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e196164717, createdName=ms8000001967238880, createdTime=Tue Jun 21 10:19:53 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113782, encodeId=8f091113e8206, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113781, encodeId=4ca11113e81fd, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188521, encodeId=6f7d2188521d0, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:营养流行病学<br>经验分享:23年10月投稿,一直待分配编辑,1个月后找到编辑,紧接着送审,审稿周期2个月,大修接收,2月19日接收,整个周期耗时4个月,好在结果不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10768099093, createdName=ms8000000199900887, createdTime=Wed Feb 21 15:42:18 CST 2024, time=2024-02-21, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2147131, encodeId=4dbd214e1314e, content=偏重的研究方向:流行病学<br>经验分享:5月份团队一篇文章被fin接收,2天后我们缴纳apc,之后突然审稿系统退到第6步,状态显示编辑要进行技术审查之类的。我们一直以为是新影响因子出来前控制稿件数量的策略,也就没在意,期间给中国编辑部发了邮件,编辑部说会跟进。新IF出来后,竟然以稿件不符合期刊标准直接拒了,你敢信??????发两封邮件质疑其初衷,直接无视,只提到apc会退回!!!目前apc还没退到账户,至于各位投还是不投,frontiers还能不能水,自己定夺!!!!!!以后应该不会投这个杂志了,出尔反尔,不知其可!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c95495864, createdName=ms8000000158580549, createdTime=Sun Jul 09 15:56:52 CST 2023, time=2023-07-09, status=1, ipAttribution=重庆)]
    2022-10-31 ms9000000819717463

    最近是不是变慢了,10天还没分配AE

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2122929, encodeId=175121229295a, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:营养<br>经验分享:常规实验文章,投稿到接收4个月左右,交了版面费很快就出刊了。 2个审稿人都是美国的。1是个大佬,问了很多细致的问题,也给了一些值得思考的建议,一一对应改好了,就给过了。2是个博后,问了几个常规的问题,也是回答就给过了。 总的来说,这两个审稿人挺友善的,杂志也很负责,要了伦理审核的东西,wb的原图,Qpcr 原数据我都附上了,都是比较规范的。 老老实实都附上,应该就会快一些吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a7f5533568, createdName=韦钰, createdTime=Fri Mar 31 10:39:08 CST 2023, time=2023-03-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2097683, encodeId=2542209e68340, content=最近是不是变慢了,10天还没分配AE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=010f8147904, createdName=ms9000000819717463, createdTime=Mon Oct 31 21:13:24 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207713, encodeId=7548120e7138b, content=微博吃瓜,投这个,哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Fri Apr 01 00:42:17 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149116, encodeId=a686214911689, content=一审2个月,不知道多久能完事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=168c2506707, createdName=发发发biu, createdTime=Fri Jul 21 09:52:15 CST 2023, time=2023-07-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2091816, encodeId=38662091816cf, content=偏重的研究方向:营养<br>经验分享:这个杂志到底按一区还是二区啊?看到中科院升级版是二区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqFQ0gs98ltXQ4kLkU7MnunH93d2ribAxPw8ImaU4UYv9NbJibibu7uPBpkESFCaibVGYQwXhxyW43icag/132, createdBy=b7021639769, createdName=babytree, createdTime=Tue Oct 04 23:29:57 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227696, encodeId=a7e0122e696f4, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:两个审稿人的审稿意见已经通过邮件的形式单独发过来了,不知道是不是还有其他审稿人。请问在哪回复审稿意见啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e196164717, createdName=ms8000001967238880, createdTime=Tue Jun 21 10:19:53 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113782, encodeId=8f091113e8206, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113781, encodeId=4ca11113e81fd, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188521, encodeId=6f7d2188521d0, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:营养流行病学<br>经验分享:23年10月投稿,一直待分配编辑,1个月后找到编辑,紧接着送审,审稿周期2个月,大修接收,2月19日接收,整个周期耗时4个月,好在结果不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10768099093, createdName=ms8000000199900887, createdTime=Wed Feb 21 15:42:18 CST 2024, time=2024-02-21, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2147131, encodeId=4dbd214e1314e, content=偏重的研究方向:流行病学<br>经验分享:5月份团队一篇文章被fin接收,2天后我们缴纳apc,之后突然审稿系统退到第6步,状态显示编辑要进行技术审查之类的。我们一直以为是新影响因子出来前控制稿件数量的策略,也就没在意,期间给中国编辑部发了邮件,编辑部说会跟进。新IF出来后,竟然以稿件不符合期刊标准直接拒了,你敢信??????发两封邮件质疑其初衷,直接无视,只提到apc会退回!!!目前apc还没退到账户,至于各位投还是不投,frontiers还能不能水,自己定夺!!!!!!以后应该不会投这个杂志了,出尔反尔,不知其可!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c95495864, createdName=ms8000000158580549, createdTime=Sun Jul 09 15:56:52 CST 2023, time=2023-07-09, status=1, ipAttribution=重庆)]
    2022-04-01 123b4903m95暂无昵称

    微博吃瓜,投这个,哈哈

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2122929, encodeId=175121229295a, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:营养<br>经验分享:常规实验文章,投稿到接收4个月左右,交了版面费很快就出刊了。 2个审稿人都是美国的。1是个大佬,问了很多细致的问题,也给了一些值得思考的建议,一一对应改好了,就给过了。2是个博后,问了几个常规的问题,也是回答就给过了。 总的来说,这两个审稿人挺友善的,杂志也很负责,要了伦理审核的东西,wb的原图,Qpcr 原数据我都附上了,都是比较规范的。 老老实实都附上,应该就会快一些吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a7f5533568, createdName=韦钰, createdTime=Fri Mar 31 10:39:08 CST 2023, time=2023-03-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2097683, encodeId=2542209e68340, content=最近是不是变慢了,10天还没分配AE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=010f8147904, createdName=ms9000000819717463, createdTime=Mon Oct 31 21:13:24 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207713, encodeId=7548120e7138b, content=微博吃瓜,投这个,哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Fri Apr 01 00:42:17 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149116, encodeId=a686214911689, content=一审2个月,不知道多久能完事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=168c2506707, createdName=发发发biu, createdTime=Fri Jul 21 09:52:15 CST 2023, time=2023-07-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2091816, encodeId=38662091816cf, content=偏重的研究方向:营养<br>经验分享:这个杂志到底按一区还是二区啊?看到中科院升级版是二区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqFQ0gs98ltXQ4kLkU7MnunH93d2ribAxPw8ImaU4UYv9NbJibibu7uPBpkESFCaibVGYQwXhxyW43icag/132, createdBy=b7021639769, createdName=babytree, createdTime=Tue Oct 04 23:29:57 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227696, encodeId=a7e0122e696f4, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:两个审稿人的审稿意见已经通过邮件的形式单独发过来了,不知道是不是还有其他审稿人。请问在哪回复审稿意见啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e196164717, createdName=ms8000001967238880, createdTime=Tue Jun 21 10:19:53 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113782, encodeId=8f091113e8206, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113781, encodeId=4ca11113e81fd, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188521, encodeId=6f7d2188521d0, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:营养流行病学<br>经验分享:23年10月投稿,一直待分配编辑,1个月后找到编辑,紧接着送审,审稿周期2个月,大修接收,2月19日接收,整个周期耗时4个月,好在结果不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10768099093, createdName=ms8000000199900887, createdTime=Wed Feb 21 15:42:18 CST 2024, time=2024-02-21, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2147131, encodeId=4dbd214e1314e, content=偏重的研究方向:流行病学<br>经验分享:5月份团队一篇文章被fin接收,2天后我们缴纳apc,之后突然审稿系统退到第6步,状态显示编辑要进行技术审查之类的。我们一直以为是新影响因子出来前控制稿件数量的策略,也就没在意,期间给中国编辑部发了邮件,编辑部说会跟进。新IF出来后,竟然以稿件不符合期刊标准直接拒了,你敢信??????发两封邮件质疑其初衷,直接无视,只提到apc会退回!!!目前apc还没退到账户,至于各位投还是不投,frontiers还能不能水,自己定夺!!!!!!以后应该不会投这个杂志了,出尔反尔,不知其可!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c95495864, createdName=ms8000000158580549, createdTime=Sun Jul 09 15:56:52 CST 2023, time=2023-07-09, status=1, ipAttribution=重庆)]
    2023-07-21 发发发biu 来自辽宁省

    一审2个月,不知道多久能完事

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2122929, encodeId=175121229295a, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:营养<br>经验分享:常规实验文章,投稿到接收4个月左右,交了版面费很快就出刊了。 2个审稿人都是美国的。1是个大佬,问了很多细致的问题,也给了一些值得思考的建议,一一对应改好了,就给过了。2是个博后,问了几个常规的问题,也是回答就给过了。 总的来说,这两个审稿人挺友善的,杂志也很负责,要了伦理审核的东西,wb的原图,Qpcr 原数据我都附上了,都是比较规范的。 老老实实都附上,应该就会快一些吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a7f5533568, createdName=韦钰, createdTime=Fri Mar 31 10:39:08 CST 2023, time=2023-03-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2097683, encodeId=2542209e68340, content=最近是不是变慢了,10天还没分配AE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=010f8147904, createdName=ms9000000819717463, createdTime=Mon Oct 31 21:13:24 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207713, encodeId=7548120e7138b, content=微博吃瓜,投这个,哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Fri Apr 01 00:42:17 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149116, encodeId=a686214911689, content=一审2个月,不知道多久能完事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=168c2506707, createdName=发发发biu, createdTime=Fri Jul 21 09:52:15 CST 2023, time=2023-07-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2091816, encodeId=38662091816cf, content=偏重的研究方向:营养<br>经验分享:这个杂志到底按一区还是二区啊?看到中科院升级版是二区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqFQ0gs98ltXQ4kLkU7MnunH93d2ribAxPw8ImaU4UYv9NbJibibu7uPBpkESFCaibVGYQwXhxyW43icag/132, createdBy=b7021639769, createdName=babytree, createdTime=Tue Oct 04 23:29:57 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227696, encodeId=a7e0122e696f4, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:两个审稿人的审稿意见已经通过邮件的形式单独发过来了,不知道是不是还有其他审稿人。请问在哪回复审稿意见啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e196164717, createdName=ms8000001967238880, createdTime=Tue Jun 21 10:19:53 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113782, encodeId=8f091113e8206, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113781, encodeId=4ca11113e81fd, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188521, encodeId=6f7d2188521d0, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:营养流行病学<br>经验分享:23年10月投稿,一直待分配编辑,1个月后找到编辑,紧接着送审,审稿周期2个月,大修接收,2月19日接收,整个周期耗时4个月,好在结果不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10768099093, createdName=ms8000000199900887, createdTime=Wed Feb 21 15:42:18 CST 2024, time=2024-02-21, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2147131, encodeId=4dbd214e1314e, content=偏重的研究方向:流行病学<br>经验分享:5月份团队一篇文章被fin接收,2天后我们缴纳apc,之后突然审稿系统退到第6步,状态显示编辑要进行技术审查之类的。我们一直以为是新影响因子出来前控制稿件数量的策略,也就没在意,期间给中国编辑部发了邮件,编辑部说会跟进。新IF出来后,竟然以稿件不符合期刊标准直接拒了,你敢信??????发两封邮件质疑其初衷,直接无视,只提到apc会退回!!!目前apc还没退到账户,至于各位投还是不投,frontiers还能不能水,自己定夺!!!!!!以后应该不会投这个杂志了,出尔反尔,不知其可!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c95495864, createdName=ms8000000158580549, createdTime=Sun Jul 09 15:56:52 CST 2023, time=2023-07-09, status=1, ipAttribution=重庆)]
    2022-10-04 babytree

    偏重的研究方向:营养
    经验分享:这个杂志到底按一区还是二区啊?看到中科院升级版是二区

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2122929, encodeId=175121229295a, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:营养<br>经验分享:常规实验文章,投稿到接收4个月左右,交了版面费很快就出刊了。 2个审稿人都是美国的。1是个大佬,问了很多细致的问题,也给了一些值得思考的建议,一一对应改好了,就给过了。2是个博后,问了几个常规的问题,也是回答就给过了。 总的来说,这两个审稿人挺友善的,杂志也很负责,要了伦理审核的东西,wb的原图,Qpcr 原数据我都附上了,都是比较规范的。 老老实实都附上,应该就会快一些吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a7f5533568, createdName=韦钰, createdTime=Fri Mar 31 10:39:08 CST 2023, time=2023-03-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2097683, encodeId=2542209e68340, content=最近是不是变慢了,10天还没分配AE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=010f8147904, createdName=ms9000000819717463, createdTime=Mon Oct 31 21:13:24 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207713, encodeId=7548120e7138b, content=微博吃瓜,投这个,哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Fri Apr 01 00:42:17 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149116, encodeId=a686214911689, content=一审2个月,不知道多久能完事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=168c2506707, createdName=发发发biu, createdTime=Fri Jul 21 09:52:15 CST 2023, time=2023-07-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2091816, encodeId=38662091816cf, content=偏重的研究方向:营养<br>经验分享:这个杂志到底按一区还是二区啊?看到中科院升级版是二区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqFQ0gs98ltXQ4kLkU7MnunH93d2ribAxPw8ImaU4UYv9NbJibibu7uPBpkESFCaibVGYQwXhxyW43icag/132, createdBy=b7021639769, createdName=babytree, createdTime=Tue Oct 04 23:29:57 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227696, encodeId=a7e0122e696f4, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:两个审稿人的审稿意见已经通过邮件的形式单独发过来了,不知道是不是还有其他审稿人。请问在哪回复审稿意见啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e196164717, createdName=ms8000001967238880, createdTime=Tue Jun 21 10:19:53 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113782, encodeId=8f091113e8206, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113781, encodeId=4ca11113e81fd, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188521, encodeId=6f7d2188521d0, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:营养流行病学<br>经验分享:23年10月投稿,一直待分配编辑,1个月后找到编辑,紧接着送审,审稿周期2个月,大修接收,2月19日接收,整个周期耗时4个月,好在结果不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10768099093, createdName=ms8000000199900887, createdTime=Wed Feb 21 15:42:18 CST 2024, time=2024-02-21, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2147131, encodeId=4dbd214e1314e, content=偏重的研究方向:流行病学<br>经验分享:5月份团队一篇文章被fin接收,2天后我们缴纳apc,之后突然审稿系统退到第6步,状态显示编辑要进行技术审查之类的。我们一直以为是新影响因子出来前控制稿件数量的策略,也就没在意,期间给中国编辑部发了邮件,编辑部说会跟进。新IF出来后,竟然以稿件不符合期刊标准直接拒了,你敢信??????发两封邮件质疑其初衷,直接无视,只提到apc会退回!!!目前apc还没退到账户,至于各位投还是不投,frontiers还能不能水,自己定夺!!!!!!以后应该不会投这个杂志了,出尔反尔,不知其可!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c95495864, createdName=ms8000000158580549, createdTime=Sun Jul 09 15:56:52 CST 2023, time=2023-07-09, status=1, ipAttribution=重庆)]
    2022-06-21 ms8000001967238880

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享:两个审稿人的审稿意见已经通过邮件的形式单独发过来了,不知道是不是还有其他审稿人。请问在哪回复审稿意见啊?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2122929, encodeId=175121229295a, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:营养<br>经验分享:常规实验文章,投稿到接收4个月左右,交了版面费很快就出刊了。 2个审稿人都是美国的。1是个大佬,问了很多细致的问题,也给了一些值得思考的建议,一一对应改好了,就给过了。2是个博后,问了几个常规的问题,也是回答就给过了。 总的来说,这两个审稿人挺友善的,杂志也很负责,要了伦理审核的东西,wb的原图,Qpcr 原数据我都附上了,都是比较规范的。 老老实实都附上,应该就会快一些吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a7f5533568, createdName=韦钰, createdTime=Fri Mar 31 10:39:08 CST 2023, time=2023-03-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2097683, encodeId=2542209e68340, content=最近是不是变慢了,10天还没分配AE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=010f8147904, createdName=ms9000000819717463, createdTime=Mon Oct 31 21:13:24 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207713, encodeId=7548120e7138b, content=微博吃瓜,投这个,哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Fri Apr 01 00:42:17 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149116, encodeId=a686214911689, content=一审2个月,不知道多久能完事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=168c2506707, createdName=发发发biu, createdTime=Fri Jul 21 09:52:15 CST 2023, time=2023-07-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2091816, encodeId=38662091816cf, content=偏重的研究方向:营养<br>经验分享:这个杂志到底按一区还是二区啊?看到中科院升级版是二区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqFQ0gs98ltXQ4kLkU7MnunH93d2ribAxPw8ImaU4UYv9NbJibibu7uPBpkESFCaibVGYQwXhxyW43icag/132, createdBy=b7021639769, createdName=babytree, createdTime=Tue Oct 04 23:29:57 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227696, encodeId=a7e0122e696f4, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:两个审稿人的审稿意见已经通过邮件的形式单独发过来了,不知道是不是还有其他审稿人。请问在哪回复审稿意见啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e196164717, createdName=ms8000001967238880, createdTime=Tue Jun 21 10:19:53 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113782, encodeId=8f091113e8206, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113781, encodeId=4ca11113e81fd, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188521, encodeId=6f7d2188521d0, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:营养流行病学<br>经验分享:23年10月投稿,一直待分配编辑,1个月后找到编辑,紧接着送审,审稿周期2个月,大修接收,2月19日接收,整个周期耗时4个月,好在结果不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10768099093, createdName=ms8000000199900887, createdTime=Wed Feb 21 15:42:18 CST 2024, time=2024-02-21, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2147131, encodeId=4dbd214e1314e, content=偏重的研究方向:流行病学<br>经验分享:5月份团队一篇文章被fin接收,2天后我们缴纳apc,之后突然审稿系统退到第6步,状态显示编辑要进行技术审查之类的。我们一直以为是新影响因子出来前控制稿件数量的策略,也就没在意,期间给中国编辑部发了邮件,编辑部说会跟进。新IF出来后,竟然以稿件不符合期刊标准直接拒了,你敢信??????发两封邮件质疑其初衷,直接无视,只提到apc会退回!!!目前apc还没退到账户,至于各位投还是不投,frontiers还能不能水,自己定夺!!!!!!以后应该不会投这个杂志了,出尔反尔,不知其可!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c95495864, createdName=ms8000000158580549, createdTime=Sun Jul 09 15:56:52 CST 2023, time=2023-07-09, status=1, ipAttribution=重庆)]
    2021-12-29 Gym璨烨

    评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2122929, encodeId=175121229295a, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:营养<br>经验分享:常规实验文章,投稿到接收4个月左右,交了版面费很快就出刊了。 2个审稿人都是美国的。1是个大佬,问了很多细致的问题,也给了一些值得思考的建议,一一对应改好了,就给过了。2是个博后,问了几个常规的问题,也是回答就给过了。 总的来说,这两个审稿人挺友善的,杂志也很负责,要了伦理审核的东西,wb的原图,Qpcr 原数据我都附上了,都是比较规范的。 老老实实都附上,应该就会快一些吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a7f5533568, createdName=韦钰, createdTime=Fri Mar 31 10:39:08 CST 2023, time=2023-03-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2097683, encodeId=2542209e68340, content=最近是不是变慢了,10天还没分配AE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=010f8147904, createdName=ms9000000819717463, createdTime=Mon Oct 31 21:13:24 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207713, encodeId=7548120e7138b, content=微博吃瓜,投这个,哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Fri Apr 01 00:42:17 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149116, encodeId=a686214911689, content=一审2个月,不知道多久能完事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=168c2506707, createdName=发发发biu, createdTime=Fri Jul 21 09:52:15 CST 2023, time=2023-07-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2091816, encodeId=38662091816cf, content=偏重的研究方向:营养<br>经验分享:这个杂志到底按一区还是二区啊?看到中科院升级版是二区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqFQ0gs98ltXQ4kLkU7MnunH93d2ribAxPw8ImaU4UYv9NbJibibu7uPBpkESFCaibVGYQwXhxyW43icag/132, createdBy=b7021639769, createdName=babytree, createdTime=Tue Oct 04 23:29:57 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227696, encodeId=a7e0122e696f4, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:两个审稿人的审稿意见已经通过邮件的形式单独发过来了,不知道是不是还有其他审稿人。请问在哪回复审稿意见啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e196164717, createdName=ms8000001967238880, createdTime=Tue Jun 21 10:19:53 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113782, encodeId=8f091113e8206, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113781, encodeId=4ca11113e81fd, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188521, encodeId=6f7d2188521d0, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:营养流行病学<br>经验分享:23年10月投稿,一直待分配编辑,1个月后找到编辑,紧接着送审,审稿周期2个月,大修接收,2月19日接收,整个周期耗时4个月,好在结果不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10768099093, createdName=ms8000000199900887, createdTime=Wed Feb 21 15:42:18 CST 2024, time=2024-02-21, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2147131, encodeId=4dbd214e1314e, content=偏重的研究方向:流行病学<br>经验分享:5月份团队一篇文章被fin接收,2天后我们缴纳apc,之后突然审稿系统退到第6步,状态显示编辑要进行技术审查之类的。我们一直以为是新影响因子出来前控制稿件数量的策略,也就没在意,期间给中国编辑部发了邮件,编辑部说会跟进。新IF出来后,竟然以稿件不符合期刊标准直接拒了,你敢信??????发两封邮件质疑其初衷,直接无视,只提到apc会退回!!!目前apc还没退到账户,至于各位投还是不投,frontiers还能不能水,自己定夺!!!!!!以后应该不会投这个杂志了,出尔反尔,不知其可!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c95495864, createdName=ms8000000158580549, createdTime=Sun Jul 09 15:56:52 CST 2023, time=2023-07-09, status=1, ipAttribution=重庆)]
    2021-12-29 小动量

    回复评审的意见和期刊编辑的意见有什么不同?

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2122929, encodeId=175121229295a, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:营养<br>经验分享:常规实验文章,投稿到接收4个月左右,交了版面费很快就出刊了。 2个审稿人都是美国的。1是个大佬,问了很多细致的问题,也给了一些值得思考的建议,一一对应改好了,就给过了。2是个博后,问了几个常规的问题,也是回答就给过了。 总的来说,这两个审稿人挺友善的,杂志也很负责,要了伦理审核的东西,wb的原图,Qpcr 原数据我都附上了,都是比较规范的。 老老实实都附上,应该就会快一些吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a7f5533568, createdName=韦钰, createdTime=Fri Mar 31 10:39:08 CST 2023, time=2023-03-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2097683, encodeId=2542209e68340, content=最近是不是变慢了,10天还没分配AE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=010f8147904, createdName=ms9000000819717463, createdTime=Mon Oct 31 21:13:24 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207713, encodeId=7548120e7138b, content=微博吃瓜,投这个,哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Fri Apr 01 00:42:17 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149116, encodeId=a686214911689, content=一审2个月,不知道多久能完事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=168c2506707, createdName=发发发biu, createdTime=Fri Jul 21 09:52:15 CST 2023, time=2023-07-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2091816, encodeId=38662091816cf, content=偏重的研究方向:营养<br>经验分享:这个杂志到底按一区还是二区啊?看到中科院升级版是二区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqFQ0gs98ltXQ4kLkU7MnunH93d2ribAxPw8ImaU4UYv9NbJibibu7uPBpkESFCaibVGYQwXhxyW43icag/132, createdBy=b7021639769, createdName=babytree, createdTime=Tue Oct 04 23:29:57 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227696, encodeId=a7e0122e696f4, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:两个审稿人的审稿意见已经通过邮件的形式单独发过来了,不知道是不是还有其他审稿人。请问在哪回复审稿意见啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e196164717, createdName=ms8000001967238880, createdTime=Tue Jun 21 10:19:53 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113782, encodeId=8f091113e8206, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113781, encodeId=4ca11113e81fd, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188521, encodeId=6f7d2188521d0, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:营养流行病学<br>经验分享:23年10月投稿,一直待分配编辑,1个月后找到编辑,紧接着送审,审稿周期2个月,大修接收,2月19日接收,整个周期耗时4个月,好在结果不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10768099093, createdName=ms8000000199900887, createdTime=Wed Feb 21 15:42:18 CST 2024, time=2024-02-21, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2147131, encodeId=4dbd214e1314e, content=偏重的研究方向:流行病学<br>经验分享:5月份团队一篇文章被fin接收,2天后我们缴纳apc,之后突然审稿系统退到第6步,状态显示编辑要进行技术审查之类的。我们一直以为是新影响因子出来前控制稿件数量的策略,也就没在意,期间给中国编辑部发了邮件,编辑部说会跟进。新IF出来后,竟然以稿件不符合期刊标准直接拒了,你敢信??????发两封邮件质疑其初衷,直接无视,只提到apc会退回!!!目前apc还没退到账户,至于各位投还是不投,frontiers还能不能水,自己定夺!!!!!!以后应该不会投这个杂志了,出尔反尔,不知其可!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c95495864, createdName=ms8000000158580549, createdTime=Sun Jul 09 15:56:52 CST 2023, time=2023-07-09, status=1, ipAttribution=重庆)]
    2024-02-21 ms8000000199900887 来自甘肃省

    审稿速度:3.0 | 投稿命中率:75.0
    偏重的研究方向:营养流行病学
    经验分享:23年10月投稿,一直待分配编辑,1个月后找到编辑,紧接着送审,审稿周期2个月,大修接收,2月19日接收,整个周期耗时4个月,好在结果不错

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2122929, encodeId=175121229295a, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:营养<br>经验分享:常规实验文章,投稿到接收4个月左右,交了版面费很快就出刊了。 2个审稿人都是美国的。1是个大佬,问了很多细致的问题,也给了一些值得思考的建议,一一对应改好了,就给过了。2是个博后,问了几个常规的问题,也是回答就给过了。 总的来说,这两个审稿人挺友善的,杂志也很负责,要了伦理审核的东西,wb的原图,Qpcr 原数据我都附上了,都是比较规范的。 老老实实都附上,应该就会快一些吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a7f5533568, createdName=韦钰, createdTime=Fri Mar 31 10:39:08 CST 2023, time=2023-03-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2097683, encodeId=2542209e68340, content=最近是不是变慢了,10天还没分配AE, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=010f8147904, createdName=ms9000000819717463, createdTime=Mon Oct 31 21:13:24 CST 2022, time=2022-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207713, encodeId=7548120e7138b, content=微博吃瓜,投这个,哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76042430158, createdName=123b4903m95暂无昵称, createdTime=Fri Apr 01 00:42:17 CST 2022, time=2022-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149116, encodeId=a686214911689, content=一审2个月,不知道多久能完事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=168c2506707, createdName=发发发biu, createdTime=Fri Jul 21 09:52:15 CST 2023, time=2023-07-21, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2091816, encodeId=38662091816cf, content=偏重的研究方向:营养<br>经验分享:这个杂志到底按一区还是二区啊?看到中科院升级版是二区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqFQ0gs98ltXQ4kLkU7MnunH93d2ribAxPw8ImaU4UYv9NbJibibu7uPBpkESFCaibVGYQwXhxyW43icag/132, createdBy=b7021639769, createdName=babytree, createdTime=Tue Oct 04 23:29:57 CST 2022, time=2022-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227696, encodeId=a7e0122e696f4, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:两个审稿人的审稿意见已经通过邮件的形式单独发过来了,不知道是不是还有其他审稿人。请问在哪回复审稿意见啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e196164717, createdName=ms8000001967238880, createdTime=Tue Jun 21 10:19:53 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113782, encodeId=8f091113e8206, content=评审要求我补充实验,可我的样品已经用完了/实验已经结束了,直接说我样本用完了会被拒稿么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113781, encodeId=4ca11113e81fd, content=回复评审的意见和期刊编辑的意见有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:55 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188521, encodeId=6f7d2188521d0, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:营养流行病学<br>经验分享:23年10月投稿,一直待分配编辑,1个月后找到编辑,紧接着送审,审稿周期2个月,大修接收,2月19日接收,整个周期耗时4个月,好在结果不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10768099093, createdName=ms8000000199900887, createdTime=Wed Feb 21 15:42:18 CST 2024, time=2024-02-21, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2147131, encodeId=4dbd214e1314e, content=偏重的研究方向:流行病学<br>经验分享:5月份团队一篇文章被fin接收,2天后我们缴纳apc,之后突然审稿系统退到第6步,状态显示编辑要进行技术审查之类的。我们一直以为是新影响因子出来前控制稿件数量的策略,也就没在意,期间给中国编辑部发了邮件,编辑部说会跟进。新IF出来后,竟然以稿件不符合期刊标准直接拒了,你敢信??????发两封邮件质疑其初衷,直接无视,只提到apc会退回!!!目前apc还没退到账户,至于各位投还是不投,frontiers还能不能水,自己定夺!!!!!!以后应该不会投这个杂志了,出尔反尔,不知其可!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34c95495864, createdName=ms8000000158580549, createdTime=Sun Jul 09 15:56:52 CST 2023, time=2023-07-09, status=1, ipAttribution=重庆)]
    2023-07-09 ms8000000158580549 来自重庆

    偏重的研究方向:流行病学
    经验分享:5月份团队一篇文章被fin接收,2天后我们缴纳apc,之后突然审稿系统退到第6步,状态显示编辑要进行技术审查之类的。我们一直以为是新影响因子出来前控制稿件数量的策略,也就没在意,期间给中国编辑部发了邮件,编辑部说会跟进。新IF出来后,竟然以稿件不符合期刊标准直接拒了,你敢信??????发两封邮件质疑其初衷,直接无视,只提到apc会退回!!!目前apc还没退到账户,至于各位投还是不投,frontiers还能不能水,自己定夺!!!!!!以后应该不会投这个杂志了,出尔反尔,不知其可!!!

    0

共103条页码: 2/11页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分